BIO-FD&C Co.,Ltd. (KOSDAQ:251120)

Market Cap	113.48B -2.1%
Revenue (ttm)	19.18B +19.4%
Net Income	6.67B +48.1%
EPS	781.00 +47.9%
Shares Out	8.70M
PE Ratio	16.71
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	51,907
Average Volume	30,628
Open	13,210
Previous Close	13,050
Day's Range	12,550 - 13,210
52-Week Range	12,500 - 23,100
Beta	0.46
RSI	27.34
Earnings Date	n/a

About BIO-FD&C

BIO-FD&C Co.,Ltd. develops active ingredients for anti-aging cosmetics in South Korea. It offers plant cell, peptide, natural extract, and biomolecule products for wrinkle improvement/skin regeneration, skin brightening, acne, skin irritation, wound healing, scalp improvement, skin moisturizing, fine dust, hair loss improvement, pores, lifting, whitening, skin texture, anti-inflammation/skin soothing, and anti-oxidation. The company was founded in 2005 and is headquartered in Incheon, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2005
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 251120

Financial Performance

In 2025, BIO-FD&C's revenue was 19.18 billion, an increase of 19.37% compared to the previous year's 16.07 billion. Earnings were 6.67 billion, an increase of 48.11%.